Stay updated on BMS-986277 with Nivolumab in Epithelial Cancers Clinical Trial
Sign up to get notified when there's something new on the BMS-986277 with Nivolumab in Epithelial Cancers Clinical Trial page.
Latest updates to the BMS-986277 with Nivolumab in Epithelial Cancers Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedLocations section updated to include site listings in Sioux Falls, South Dakota and Ontario (Ottawa and Toronto). The page revision is updated to v3.3.3.SummaryDifference0.3%
- Check20 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check42 days agoChange DetectedRevision: v3.3.2 appears on the page, replacing the previous v3.2.0 label. This is a minor UI update that does not affect the study details.SummaryDifference0.0%
- Check49 days agoChange DetectedRemoved the notice about a lapse in government funding and the related operating status information (cc.nih.gov and opm.gov) from the page.SummaryDifference0.3%
- Check64 days agoChange DetectedNo substantive additions or deletions were observed; the study details and eligibility criteria appear unchanged.SummaryDifference0.4%
- Check92 days agoChange DetectedAdditions introduce a government funding notice and an operating-status update (plus a version bump to v3.2.0); the deletion removes the previous version tag v3.1.0.SummaryDifference3%
- Check100 days agoChange DetectedUpgrade from v3.0.2 to v3.1.0: version metadata updated; no substantive content changes detected.SummaryDifference0.1%
Stay in the know with updates to BMS-986277 with Nivolumab in Epithelial Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BMS-986277 with Nivolumab in Epithelial Cancers Clinical Trial page.